18 May 2022 | BST (UTC+1)

Dirk Brockstedt

Chief Scientific Officer
RAPT Therapeutics
Dirk Brockstedt
Dirk joined RAPT Therapeutics in January 2018, bringing over 20 years of experience through all stages of discovery, translational and clinical development, as well as a deep knowledge of immunology and the tumor microenvironment. He joined RAPT from Aduro Biotech, where he served as Executive Vice President of Research and Development. Prior to Aduro, Dirk held positions of increasing responsibility within the immunology department of Cerus Corporation, most recently serving as Director of Immunology. Prior to Cerus, he served as a scientist at Aventis in the immunotherapy and anti-angiogenesis group, developing novel therapies against cancer. Dirk holds an M.S. in Microbiology from the University of Kiel, and he earned his Ph.D. from the University of Kiel (graduate work performed at Stanford University). He was a post-doctoral fellow at the Stanford School of Medicine in the Department of Pathology. He has co-authored over 50 scientific papers and is a named inventor on seven issued patents and several pending applications.


No data was found

Other Speakers

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Download Brochure

Full details regarding the Immuno Series UK are available for download in the Conference Brochure